查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1817967

2032 年生物活性玻璃市场预测：按类型、形式、技术、应用、最终用户和地区进行的全球分析

Bioactive Glasses Market Forecasts to 2032 - Global Analysis By Type (Silicate-Based Bioactive Glasses, Borate-Based Bioactive Glasses, Phosphate-Based Bioactive Glasses, and Other Types), Form, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生物活性玻璃市场预计在 2025 年达到 13 亿美元，到 2032 年将达到 20 亿美元，预测期内的复合年增长率为 6.4%。

生物活性玻璃是一种独特的生物材料，由二氧化硅、氧化钙、氧化钠和五氧化二磷组成，可与生物组织结合。植入后，它会释放离子来刺激细胞活性，促进骨再生，并形成类似天然骨矿物质的羟基碳酸盐磷灰石层。它广泛应用于牙科、整形外科、创伤治疗等领域。其生物相容性、抗菌特性以及与生物系统的整合能力使其有别于惰性植入材料，在再生医学应用上具有重要价值。

根据 FDA 的说法，生物活性玻璃支架被核准用作移植骨替代物，因为它们可以与活组织主动结合并促进自然骨再生。

全球老龄人口正在增加

全球人口老化正在推动生物活性玻璃的需求，尤其是在牙科、整形外科和骨再生应用领域。老年人患有骨质疏鬆症、骨折和牙齿脱落的几率更高，这促使人们采用先进的生物材料进行组织修復和植入。生物活性玻璃以其优异的生物活性和相容性，作为传统植入物的替代品正日益受到欢迎。这种人口结构的变化正推动全球医疗保健系统越来越多地采用创新生医材料来患者照护，从而确保市场持续成长。

生物活性玻璃产品高成本

儘管生物活性玻璃产品具有强大的治疗潜力，但由于高成本，市场面临巨大限制。复杂的製造流程、昂贵的原材料以及严格的监管要求推高了生产成本。这些成本限制了其在价格敏感型市场的供应，并阻碍了其在新兴经济体的广泛应用。此外，当有更便宜的替代品时，医疗保健提供者可能会犹豫是否建议昂贵的生医材料。如果没有成本效益高的製造技术和可扩展的生产技术的进步，高昂的价格障碍可能会严重限制其在全球医疗保健生态系统中的广泛市场渗透。

创新产品形式的开发

被覆剂、颗粒和注射粉等新产品形式的开发，为生物活性玻璃提供了诱人的成长机会。这些创新增强了临床多功能性，并使其在牙科、创伤治疗和整形外科实现客製化应用。奈米结构生物活性玻璃和混合复合材料的研究正在扩大治疗可能性。此外，学术机构和医疗设备公司之间的合作正在加速产品商业化。透过扩展可用性和改善治疗效果，创新产品形式有望在已开发和新兴医疗保健市场中得到更广泛的应用。

医疗保健领域的限制性报销政策

缺乏优惠的报销政策对生物活性玻璃技术的推广构成了重大威胁。许多医疗保健系统将生物活性玻璃归类为非必需或高端疗法，导致患者自付费用高昂。这种经济负担限制了市场渗透，尤其是在中低收入地区。此外，有限的保险覆盖范围也阻碍了医院和诊所大规模采用此类先进的生物材料。除非报销政策扩大到涵盖生物活性解决方案，否则儘管其具有临床有效性，其成长前景仍可能受到抑制。

COVID-19的影响：

新冠疫情扰乱了供应链，推迟了选择性医疗程序，并对牙科和整形外科对生物活性玻璃的需求产生了负面影响。许多医疗系统优先考虑严重监护，并推迟了非紧急手术和植入治疗。然而，疫情加速了再生医学和生物材料研究的创新，为生物活性解决方案创造了新的机会。随着选择性手术的恢復，强劲的需求预计将推动復苏。总体而言，虽然新冠疫情带来了短期挑战，但也增强了生物活性玻璃在先进医疗保健领域的长期相关性。

预计硅酸盐基生物活性玻璃市场在预测期内将占据最大份额

硅酸盐基生物活性玻璃因其成熟的临床性能和广泛的治疗应用，预计将占据市场主导地位。这些材料表现出优异的生物活性，可促进与骨骼和牙组织的有效结合。广泛的研究支援、商业化产品的可用性以及在植入和涂层领域的成功应用，巩固了该领域的领先地位。此外，良好的机械性能和易于製造的特性使硅酸盐基玻璃成为生物医学工程的首选。对成熟可靠的生物材料日益增长的需求，使该领域占据市场主导地位。

预计预测期内粉末部分将以最高的复合年增长率成长。

由于粉末在微创手术和组织工程应用中的应用日益广泛，预计其在预测期内的复合年增长率最高。粉状生物活性玻璃用途广泛，可增加细胞交互作用的表面积，加速癒合。它可製成注射剂型并可嵌入支架，使其在再生医学领域极具吸引力。奈米技术的进步进一步提升了疗效并促进了产品创新。随着临床对灵活高效生医材料的需求不断增长，粉末领域有望快速成长。

比最大的地区

由于医疗基础设施的不断扩张、医疗旅游业的蓬勃发展以及老年人口的不断增长，亚太地区预计将占据最大的市场份额。中国、印度和日本等国家对牙科和整形外科领域先进生医材料的需求正在不断增长。政府支持医疗现代化的倡议以及不断增长的可支配收入进一步刺激了这些材料的采用。此外，强大的研发实力和本地製造能力也巩固了该地区的地位。这些因素共同确保了亚太地区成为生物活性玻璃的主要产生收入地区。

复合年增长率最高的地区：

北美预计将实现最高的复合年增长率，这与强劲的技术创新和先进生物材料的广泛应用息息相关。该地区受益于完善的医疗基础设施、广泛的临床研究以及早期的监管核准。骨科疾病和牙科疾病的高发性推动了医院和专科诊所对生物活性玻璃的需求。此外，大学、新兴企业和医疗设备公司之间的策略联盟正在加速技术创新。强大的患者意识和医疗保健支出使北美成为成长最快的区域市场。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物活性玻璃市场类型

  • 硅酸盐基生物活性玻璃
  • 硼酸盐基生物活性玻璃
  • 磷酸盐基生物活性玻璃
  • 其他类型

6. 全球生物活性玻璃市场（依形式）

  • 粉末
  • 纤维
  • 颗粒

7. 全球生物活性玻璃市场（按技术）

  • 熔体淬火
  • 溶胶-凝胶法
  • 火焰合成
  • 其他技术

8. 全球生物活性玻璃市场（依应用）

  • 骨再生
  • 牙科护理
  • 整形外科植入和涂层
  • 伤口癒合
  • 药物输送

9. 全球生物活性玻璃市场（依最终用户）

  • 医院和诊所
  • 牙医诊所
  • 研究机构
  • 医疗设备製造商

第 10 章全球生物活性玻璃市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第 12 章：公司概况

  • SCHOTT AG
  • Mo-Sci Corporation
  • Noraker
  • Vitryxx AG
  • NovaBone Products LLC
  • Stryker Corporation
  • BonAlive Biomaterials Ltd
  • Zimmer Biomet Holdings Inc.
  • Corning Incorporated
  • Sinanen Zeomic Co. Ltd.
  • Arthrex Inc.
  • DePuy Synthes（Johnson & Johnson）
  • Biomet 3i LLC
  • Dentsply Sirona Inc.
  • Mitsubishi Chemical Corporation
  • Matexcel
Product Code: SMRC30930

According to Stratistics MRC, the Global Bioactive Glasses Market is accounted for $1.3 billion in 2025 and is expected to reach $2.0 billion by 2032 growing at a CAGR of 6.4% during the forecast period. Bioactive glasses are specialized biomaterials composed of silica, calcium oxide, sodium oxide, and phosphorous pentoxide that bond with living tissues. When implanted, they release ions that stimulate cellular activity, promote bone regeneration, and form a hydroxycarbonate apatite layer similar to natural bone mineral. They are widely used in dentistry, orthopedics, and wound healing. Their biocompatibility, antimicrobial properties, and ability to integrate with biological systems distinguish them from inert implant materials, making them valuable in regenerative medicine applications.

According to the FDA, bioactive glass scaffolds are approved for use in bone graft substitutes, as they actively bond with living tissue and stimulate natural bone regeneration.

Market Dynamics:

Driver:

Growing aging population globally

The global rise in the aging population is fueling demand for bioactive glasses, particularly in dental, orthopedic, and bone regeneration applications. Elderly individuals face higher incidences of osteoporosis, fractures, and tooth loss, spurring adoption of advanced biomaterials for tissue repair and implants. Bioactive glasses, with their excellent bioactivity and compatibility, are gaining traction as substitutes for traditional grafts. This demographic shift ensures sustained market growth, as healthcare systems worldwide increasingly turn to innovative biomaterials for elderly patient care.

Restraint:

High cost of bioactive glass products

Despite strong therapeutic potential, the market faces a significant restraint due to the high cost of bioactive glass products. Complex manufacturing processes, expensive raw materials, and stringent regulatory requirements elevate production expenses. These costs limit accessibility in price-sensitive markets, hindering widespread adoption in developing economies. Additionally, healthcare providers may hesitate to recommend premium biomaterials when cheaper alternatives exist. Without cost-effective manufacturing advancements and scalable production techniques, the high pricing barrier could significantly restrict broader market penetration across global healthcare ecosystems.

Opportunity:

Development of innovative product forms

The development of novel product forms such as coatings, granules, and injectable powders offers a compelling growth opportunity for bioactive glasses. These innovations enhance clinical versatility, allowing tailored applications in dentistry, wound healing, and orthopedics. Research into nano-structured bioactive glasses and hybrid composites is expanding therapeutic possibilities. Furthermore, collaborations between academic institutions and medical device companies accelerate product commercialization. By broadening usability and improving outcomes, innovative product formats are set to attract wider adoption across both advanced and emerging healthcare markets.

Threat:

Limited reimbursement policies in healthcare

The lack of favorable reimbursement frameworks poses a critical threat to the adoption of bioactive glass technologies. Many healthcare systems categorize bioactive glasses as non-essential or premium therapies, resulting in out-of-pocket costs for patients. This financial burden restricts market penetration, particularly in low- and middle-income regions. Moreover, limited insurance coverage discourages hospitals and clinics from adopting these advanced biomaterials at scale. Unless reimbursement policies expand to include bioactive solutions, growth prospects may be curtailed despite their clinical effectiveness.

Covid-19 Impact:

The COVID-19 pandemic disrupted supply chains and delayed elective medical procedures, negatively impacting demand for bioactive glasses in dentistry and orthopedics. Many healthcare systems prioritized critical care, postponing non-urgent surgeries and implant treatments. However, the pandemic also accelerated innovation in regenerative medicine and biomaterials research, opening new opportunities for bioactive solutions. As elective procedures resume, pent-up demand is expected to fuel recovery. Overall, while COVID-19 created short-term challenges, it reinforced the long-term relevance of bioactive glasses in advanced healthcare.

The silicate-based bioactive glasses segment is expected to be the largest during the forecast period

The silicate-based bioactive glasses segment is expected to dominate the market due to its well-established clinical performance and broad therapeutic applications. These materials exhibit superior bioactivity, promoting effective bonding with bone and dental tissues. Extensive research backing, availability of commercialized products, and successful use in implants and coatings strengthen this segment's leadership. Moreover, favorable mechanical properties and ease of fabrication make silicate-based glasses a preferred choice in biomedical engineering. As demand for proven and reliable biomaterials rises, this segment secures its market dominance.

The powders segment is expected to have the highest CAGR during the forecast period

The powders segment is anticipated to witness the highest CAGR during the forecast period, reinforced by its growing use in minimally invasive procedures and tissue engineering applications. Powdered bioactive glasses are versatile, offering enhanced surface area for cellular interaction and faster healing outcomes. Their adaptability in injectable forms and incorporation into scaffolds boosts appeal in regenerative medicine. Advancements in nanotechnology further enhance efficacy and product innovation. With rising clinical demand for flexible and effective biomaterials, the powders segment is poised for rapid growth.

Region with largest share:

Asia Pacific is expected to command the largest market share, ascribed to its expanding healthcare infrastructure, rising medical tourism, and growing geriatric population. Countries such as China, India, and Japan are witnessing increased demand for advanced biomaterials in dentistry and orthopedics. Government initiatives supporting healthcare modernization and rising disposable incomes further accelerate adoption. Additionally, strong R&D presence and local manufacturing capacities strengthen the region's position. Collectively, these factors ensure Asia Pacific's dominance as the leading revenue-generating region for bioactive glasses.

Region with highest CAGR:

North America is projected to record the highest CAGR, associated with strong technological innovation and robust adoption of advanced biomaterials. The region benefits from well-established healthcare infrastructure, extensive clinical research, and early regulatory approvals. High prevalence of bone-related conditions and dental disorders fuels demand for bioactive glasses in both hospitals and specialty clinics. Additionally, strategic collaborations between universities, startups, and medical device companies accelerate innovation. With strong patient awareness and healthcare spending, North America emerges as the fastest-growing regional market.

Key players in the market

Some of the key players in Bioactive Glasses Market include SCHOTT AG, Mo-Sci Corporation, Noraker, Vitryxx AG, NovaBone Products LLC, Stryker Corporation, BonAlive Biomaterials Ltd, Zimmer Biomet Holdings Inc., Corning Incorporated, Sinanen Zeomic Co. Ltd., Arthrex Inc., DePuy Synthes (Johnson & Johnson), Biomet 3i LLC, Dentsply Sirona Inc., Mitsubishi Chemical Corporation, and Matexcel.

Key Developments:

In Sep 2025, SCHOTT AG introduced bioactive glass granules with a customized strontium and zinc ion release profile, designed to significantly enhance osteoblast activity and accelerate bone regeneration in spinal fusion procedures.

In Aug 2025, Mo-Sci Corporation launched its PerioGlas(R) Shield, a new injectable putty for periodontal bone defects that provides a physical barrier and sustained release of silicate ions to promote periodontal ligament attachment and alveolar bone repair.

In July 2025, Stryker Corporation announced the launch of NovaBone(R) Dental Putty with Silver, a first-to-market formulation that combines the osteoconductive properties of bioactive glass with the antimicrobial efficacy of silver ions for infected dental extraction sites.

Types Covered:

  • Silicate-Based Bioactive Glasses
  • Borate-Based Bioactive Glasses
  • Phosphate-Based Bioactive Glasses
  • Other Types

Forms Covered:

  • Powders
  • Fibers
  • Granules

Technologies Covered:

  • Melt Quenching
  • Sol-Gel Process
  • Flame Synthesis
  • Other Technologies

Applications Covered:

  • Bone Regeneration
  • Dental Care
  • Orthopedic Implants & Coatings
  • Wound Healing
  • Drug Delivery

End Users Covered:

  • Hospitals & Clinics
  • Dental Clinics
  • Research Institutes
  • Medical Device Manufacturers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioactive Glasses Market, By Type

  • 5.1 Introduction
  • 5.2 Silicate-Based Bioactive Glasses
  • 5.3 Borate-Based Bioactive Glasses
  • 5.4 Phosphate-Based Bioactive Glasses
  • 5.5 Other Types

6 Global Bioactive Glasses Market, By Form

  • 6.1 Introduction
  • 6.2 Powders
  • 6.3 Fibers
  • 6.4 Granules

7 Global Bioactive Glasses Market, By Technology

  • 7.1 Introduction
  • 7.2 Melt Quenching
  • 7.3 Sol-Gel Process
  • 7.4 Flame Synthesis
  • 7.5 Other Technologies

8 Global Bioactive Glasses Market, By Application

  • 8.1 Introduction
  • 8.2 Bone Regeneration
  • 8.3 Dental Care
  • 8.4 Orthopedic Implants & Coatings
  • 8.5 Wound Healing
  • 8.6 Drug Delivery

9 Global Bioactive Glasses Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Dental Clinics
  • 9.4 Research Institutes
  • 9.5 Medical Device Manufacturers

10 Global Bioactive Glasses Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 SCHOTT AG
  • 12.2 Mo-Sci Corporation
  • 12.3 Noraker
  • 12.4 Vitryxx AG
  • 12.5 NovaBone Products LLC
  • 12.6 Stryker Corporation
  • 12.7 BonAlive Biomaterials Ltd
  • 12.8 Zimmer Biomet Holdings Inc.
  • 12.9 Corning Incorporated
  • 12.10 Sinanen Zeomic Co. Ltd.
  • 12.11 Arthrex Inc.
  • 12.12 DePuy Synthes (Johnson & Johnson)
  • 12.13 Biomet 3i LLC
  • 12.14 Dentsply Sirona Inc.
  • 12.15 Mitsubishi Chemical Corporation
  • 12.16 Matexcel

List of Tables

  • Table 1 Global Bioactive Glasses Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Bioactive Glasses Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Bioactive Glasses Market Outlook, By Silicate-Based Bioactive Glasses (2024-2032) ($MN)
  • Table 4 Global Bioactive Glasses Market Outlook, By Borate-Based Bioactive Glasses (2024-2032) ($MN)
  • Table 5 Global Bioactive Glasses Market Outlook, By Phosphate-Based Bioactive Glasses (2024-2032) ($MN)
  • Table 6 Global Bioactive Glasses Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 7 Global Bioactive Glasses Market Outlook, By Form (2024-2032) ($MN)
  • Table 8 Global Bioactive Glasses Market Outlook, By Powders (2024-2032) ($MN)
  • Table 9 Global Bioactive Glasses Market Outlook, By Fibers (2024-2032) ($MN)
  • Table 10 Global Bioactive Glasses Market Outlook, By Granules (2024-2032) ($MN)
  • Table 11 Global Bioactive Glasses Market Outlook, By Technology (2024-2032) ($MN)
  • Table 12 Global Bioactive Glasses Market Outlook, By Melt Quenching (2024-2032) ($MN)
  • Table 13 Global Bioactive Glasses Market Outlook, By Sol-Gel Process (2024-2032) ($MN)
  • Table 14 Global Bioactive Glasses Market Outlook, By Flame Synthesis (2024-2032) ($MN)
  • Table 15 Global Bioactive Glasses Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 16 Global Bioactive Glasses Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Bioactive Glasses Market Outlook, By Bone Regeneration (2024-2032) ($MN)
  • Table 18 Global Bioactive Glasses Market Outlook, By Dental Care (2024-2032) ($MN)
  • Table 19 Global Bioactive Glasses Market Outlook, By Orthopedic Implants & Coatings (2024-2032) ($MN)
  • Table 20 Global Bioactive Glasses Market Outlook, By Wound Healing (2024-2032) ($MN)
  • Table 21 Global Bioactive Glasses Market Outlook, By Drug Delivery (2024-2032) ($MN)
  • Table 22 Global Bioactive Glasses Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Bioactive Glasses Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 24 Global Bioactive Glasses Market Outlook, By Dental Clinics (2024-2032) ($MN)
  • Table 25 Global Bioactive Glasses Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 26 Global Bioactive Glasses Market Outlook, By Medical Device Manufacturers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.